<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01555411</url>
  </required_header>
  <id_info>
    <org_study_id>2011/1475 C</org_study_id>
    <secondary_id>AFIA (initial study name)</secondary_id>
    <nct_id>NCT01555411</nct_id>
  </id_info>
  <brief_title>Akershus Cardiac Examination (ACE) 1950 Study</brief_title>
  <acronym>ACE1950</acronym>
  <official_title>Akershus Cardiac Examination 1950 Study - a Cohort Study on Cardio- and Cerebrovascular Disease in 62-65-year-old Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vestre Viken Hospital Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Akershus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vestre Viken Hospital Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Akershus Cardiac Examination (ACE) 1950 Study is a large, observational, prospective,
      longitudinal, population-based cohort study. The overall aim is to establish an extensive
      cardio- and cerebrovascular age cohort of elderly subjects for various longitudinal long-term
      follow-up studies of cardiovascular and cerebrovascular disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design: The Akershus Cardiac Examination (ACE) 1950 Study is a population-based, prospective,
      cerebro- and cardiovascular age-cohort study of all men and women born in 1950 in Akershus
      County, Norway.

      Time schedule: Study inclusion and baseline examinations took place in the period September
      2012 - May 2015. Follow-up and sub-studies are ongoing.

      Current status: As per May 2018, follow-up and sub-studies are ongoing.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">December 2050</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Outcomes related to CVD and CV-associated conditions</measure>
    <time_frame>Maximum 35 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Specific CV endpoints; e.g. acute myocardial infarction, heart failure, atrial fibrillation, etc.</measure>
    <time_frame>Maximum 35 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specific CV-associated conditions, including renal, cerebrovascular, pulmonary, etc.</measure>
    <time_frame>Maximum 35 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specific clinical phenotypes; e.g. myocardial and arterial structure and function, lung function, etc.</measure>
    <time_frame>Maximum 35 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Impact of left atrial size and function measurements by echocardiography on stroke risk in an 62-65-year-old cohort</measure>
    <time_frame>Within 35 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Relation between cognitive function and sub-clinical CVD in a 62-65-year-old Norwegian population cohort</measure>
    <time_frame>Maximum 35 years</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3706</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Heart Failure</condition>
  <condition>Mild Cognitive Impairment</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Cerebrovascular Disorders</condition>
  <arm_group>
    <arm_group_label>No treatment</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples, including for genetic testing, and urine.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Residents of Akershus County, Norway, born in 1950.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Resident in Akershus County (as per October 2011, prior to study invitation)

          -  Born in the year of 1950

          -  Ability to consent to participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>62 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnljot Tveit, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Vestre Viken Hospital Trust, Department of Medical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Helge Røsjø, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Akershus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Trygve Berge - member of steering committee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vestre Viken Hospital Trust, Department of Medical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pål Smith - member of steering committee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Akershus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kjetil Steine - member of steering committee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Akershus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Torbjørn Omland - member of steering committee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Akershus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Magnus N Lyngbakken - member of steering committee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Akershus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Akershus University Hospital</name>
      <address>
        <city>Lørenskog</city>
        <state>Akershus</state>
        <zip>1478</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vestre Viken HT, Baerum Hospital, Department of Medical Research</name>
      <address>
        <city>Sandvika</city>
        <state>Akershus</state>
        <zip>3004</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <link>
    <url>http://www.ace1950.no</url>
    <description>Study website</description>
  </link>
  <reference>
    <citation>Berge T, Vigen T, Pervez MO, Ihle-Hansen H, Lyngbakken MN, Omland T, Smith P, Steine K, Røsjø H, Tveit A; ACE 1950 Study Group. Heart and Brain Interactions--the Akershus Cardiac Examination (ACE) 1950 Study Design. Scand Cardiovasc J. 2015;49(6):308-15. doi: 10.3109/14017431.2015.1086813. Epub 2015 Sep 12.</citation>
    <PMID>26364744</PMID>
  </reference>
  <results_reference>
    <citation>Ihle-Hansen H, Vigen T, Berge T, Einvik G, Aarsland D, Rønning OM, Thommessen B, Røsjø H, Tveit A, Ihle-Hansen H. Montreal Cognitive Assessment in a 63- to 65-year-old Norwegian Cohort from the General Population: Data from the Akershus Cardiac Examination 1950 Study. Dement Geriatr Cogn Dis Extra. 2017 Sep 28;7(3):318-327. doi: 10.1159/000480496. eCollection 2017 Sep-Dec.</citation>
    <PMID>29118784</PMID>
  </results_reference>
  <results_reference>
    <citation>Berge T, Brynildsen J, Larssen HKN, Onarheim S, Jenssen GR, Ihle-Hansen H, Christophersen IE, Myrstad M, Røsjø H, Smith P, Tveit A. Systematic screening for atrial fibrillation in a 65-year-old population with risk factors for stroke: data from the Akershus Cardiac Examination 1950 study. Europace. 2017 Oct 31. doi: 10.1093/europace/eux293. [Epub ahead of print]</citation>
    <PMID>29095966</PMID>
  </results_reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2012</study_first_submitted>
  <study_first_submitted_qc>March 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2012</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiovascular epidemiology</keyword>
  <keyword>Prospective, observational cohort study</keyword>
  <keyword>Biomarkers</keyword>
  <keyword>Cardio- and cerebrovascular imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Cerebrovascular Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

